Bayer AG News and Global Life Sciences & Healthcare Innovation Updates
First Solar seen as tariff-driven opportunity in U.S. clean energy sector
Energy policy is again shaping investor sentiment across the U.S. power market as upcoming trade decisions and shifting views on electricity costs influence sector valuations. Solar shares, ...
Deutsche Bank upgrades First Solar as U.S. trade policy shift seen lifting shares
After a steep recent selloff, First Solar is drawing renewed support from Wall Street as investors weigh the outcome of a U.S. investigation into polysilicon imports. Deutsche Bank says the stock ...
Bayer seeks U.S. duties on Chinese glyphosate imports amid farmer backlash
Trade tensions in the U.S. farm chemicals market are rising as Bayer pushes for import duties on Chinese-made glyphosate used in Roundup. The request comes as farmers face prolonged pressure from ...
Bayer faces U.S. antitrust suit over GMO corn seed market
A new private antitrust case is intensifying scrutiny of competition in the U.S. agricultural inputs sector as farmers contend with persistently high seed and fertilizer costs. The lawsuit accuses ...
Bayer CropScience drops seed loyalty provisions after U.S. antitrust scrutiny
Federal antitrust scrutiny of corn and soybean seed markets is prompting changes to Bayer CropScience LLC's commercial terms with independent seed companies. The company has removed provisions the ...
BAYN news live: volatility moderate — oscillators warn of weak short-term strength
Bayer AG (BAYN) is currently priced at $27.58, trading just below both the MA-20 ($27.80) and MA-50 ($27.83), but remains well above the MA-200 ($24.96). This configuration indicates short- and ...
Bayer consolidates near $27.39, after momentum oscillators signal oversold conditions
Bayer AG (BAYN) trades at $27.39, sitting below both the MA-20 ($27.80) and MA-50 ($27.80), but still above the MA-200 ($24.92). This configuration suggests short- and medium-term bearish ...
Q3 results anticipation — Bayer price forecast signals 1.73% gain amid mixed momentum
Bayer AG (BAYN) is currently trading at $27.28, showing a daily gain of $0.47 or 1.73%. The price remains below both the MA-20 at $27.80 and MA-50 at $27.76, but is well supported above the MA-200 ...
